| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Accuracy of package inserts of SARS-CoV-2 rapid antigen tests: a secondary analysis of manufacturer versus systematic review data
|
Bigio, Jacob
|
|
|
4 |
11 |
p. e875-e882
|
artikel
|
| 2 |
Africa's post-pandemic vaccination landscape
|
Adepoju, Paul
|
|
|
4 |
11 |
p. e862
|
artikel
|
| 3 |
AMR is more complicated than a lack of drugs
|
The Lancet Microbe,
|
|
|
4 |
11 |
p. e851
|
artikel
|
| 4 |
Correction to Lancet Microbe 2023; 4: e683–91
|
|
|
|
4 |
11 |
p. e860
|
artikel
|
| 5 |
Determinants of passive antibody efficacy in SARS-CoV-2 infection: a systematic review and meta-analysis
|
Stadler, Eva
|
|
|
4 |
11 |
p. e883-e892
|
artikel
|
| 6 |
Economic evaluations of whole-genome sequencing for pathogen identification in public health surveillance and health-care-associated infections: a systematic review
|
Tran, My
|
|
|
4 |
11 |
p. e953-e962
|
artikel
|
| 7 |
Effect of amoxicillin on the gut microbiome of children with severe acute malnutrition in Madarounfa, Niger: a retrospective metagenomic analysis of a placebo-controlled trial
|
Schwartz, Drew J
|
|
|
4 |
11 |
p. e931-e942
|
artikel
|
| 8 |
Effect of seven anti-tuberculosis treatment regimens on sputum microbiome: a retrospective analysis of the HIGHRIF study 2 and PanACEA MAMS-TB clinical trials
|
Musisi, Emmanuel
|
|
|
4 |
11 |
p. e913-e922
|
artikel
|
| 9 |
Immunogenicity and safety of AZD2816, a beta (B.1.351) variant COVID-19 vaccine, and AZD1222 (ChAdOx1 nCoV-19) as third-dose boosters for previously vaccinated adults: a multicentre, randomised, partly double-blinded, phase 2/3 non-inferiority immunobridging study in the UK and Poland
|
Ramasamy, Maheshi N
|
|
|
4 |
11 |
p. e863-e874
|
artikel
|
| 10 |
Investment in biosafety and biosecurity: the need for a risk-based approach and systematic reporting of laboratory accidents to mitigate laboratory-acquired infections and pathogen escapes
|
Blacksell, Stuart D
|
|
|
4 |
11 |
p. e854-e855
|
artikel
|
| 11 |
Is it possible to generalise superspreading individuals or events of SARS-CoV-2?
|
Shrestha, Sunil
|
|
|
4 |
11 |
p. e858
|
artikel
|
| 12 |
Is it possible to generalise superspreading individuals or events of SARS-CoV-2? – Authors' reply
|
Zhou, Jie
|
|
|
4 |
11 |
p. e859
|
artikel
|
| 13 |
Low prevalence of asymptomatic mpox in populations at high risk
|
Hampel, Benjamin
|
|
|
4 |
11 |
p. e856
|
artikel
|
| 14 |
Malaria eliminated in Belize
|
Venkatesan, Priya
|
|
|
4 |
11 |
p. e861
|
artikel
|
| 15 |
Persistence of immunity following a single dose of inactivated poliovirus vaccine: a phase 4, open label, non-randomised clinical trial
|
Sharma, Arun K
|
|
|
4 |
11 |
p. e923-e930
|
artikel
|
| 16 |
Population structure and antimicrobial resistance among Klebsiella isolates sampled from human, animal, and environmental sources in Ghana: a cross-sectional genomic One Health study
|
Calland, Jessica K
|
|
|
4 |
11 |
p. e943-e952
|
artikel
|
| 17 |
Severity of influenza-associated hospitalisations by influenza virus type and subtype in the USA, 2010–19: a repeated cross-sectional study
|
Sumner, Kelsey M
|
|
|
4 |
11 |
p. e903-e912
|
artikel
|
| 18 |
The emergence of tet(X) variants highlight challenges for the global genomic surveillance of tigecycline resistance
|
Rueda Furlan, João Pedro
|
|
|
4 |
11 |
p. e857
|
artikel
|
| 19 |
Transplacental transfer efficiency of maternal antibodies against influenza A(H1N1)pdm09 virus and dynamics of naturally acquired antibodies in Chinese children: a longitudinal, paired mother–neonate cohort study
|
Li, Mei
|
|
|
4 |
11 |
p. e893-e902
|
artikel
|
| 20 |
Why is the UK subscription model for antibiotics considered successful?
|
Glover, Rebecca E
|
|
|
4 |
11 |
p. e852-e853
|
artikel
|
Tijdschrift beschrijving